In fact, low concentrations of LAS194046 combined with sub-effective concentrations of fluticasone propionate showed additive/synergic effects reducing IL-8, MMP9 and superoxide anion secretion in neutrophils from severe asthma and COPD patients, thus improving the corticosteroid insensitivity. This evidence concerns the gene MMP9 and asthma.